|
Volumn 6, Issue 6, 2005, Pages 371-384
|
Preclinical pharmacology of bilastine, a new selective histamine H 1 receptor antagonist: Receptor selectivity and in Vitro antihistaminic activity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR;
BILASTINE;
BRADYKININ;
CALCIUM;
HISTAMINE H1 RECEPTOR;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H2 RECEPTOR;
HISTAMINE H3 RECEPTOR;
LEUKOTRIENE D4;
MEPYRAMINE;
MUSCARINIC M3 RECEPTOR;
SEROTONIN;
TRITIUM;
UNCLASSIFIED DRUG;
ANIMAL TISSUE;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
BINDING AFFINITY;
CELL LINE;
CEREBELLUM;
CONTROLLED STUDY;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG SELECTIVITY;
EMBRYO;
GUINEA PIG;
HUMAN;
HUMAN CELL;
ILEUM;
IN VITRO STUDY;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
RECEPTOR BLOCKING;
SMOOTH MUSCLE;
ANIMALS;
BENZIMIDAZOLES;
BINDING, COMPETITIVE;
CELL LINE;
DRUG EVALUATION, PRECLINICAL;
GUINEA PIGS;
HISTAMINE H1 ANTAGONISTS;
HUMANS;
MALE;
ORGAN SPECIFICITY;
PIPERIDINES;
PROTEIN BINDING;
RABBITS;
RATS;
RECEPTORS, HISTAMINE H1;
|
EID: 27744581978
PISSN: 11745886
EISSN: 11745886
Source Type: Journal
DOI: 10.2165/00126839-200506060-00005 Document Type: Article |
Times cited : (93)
|
References (11)
|